Compare RILY & EIKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RILY | EIKN |
|---|---|---|
| Founded | 1973 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 349.8M | 316.3M |
| IPO Year | 2014 | 2026 |
| Metric | RILY | EIKN |
|---|---|---|
| Price | $3.98 | $6.77 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $24.33 |
| AVG Volume (30 Days) | ★ 866.1K | 525.7K |
| Earning Date | 11-05-2026 | 11-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 138.49 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $967,599,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 15.38 | N/A |
| 52 Week Low | $3.49 | $5.01 |
| 52 Week High | $11.24 | $16.50 |
| Indicator | RILY | EIKN |
|---|---|---|
| Relative Strength Index (RSI) | 40.25 | 50.02 |
| Support Level | N/A | $5.01 |
| Resistance Level | $4.54 | $8.48 |
| Average True Range (ATR) | 0.28 | 0.70 |
| MACD | 0.04 | 0.13 |
| Stochastic Oscillator | 43.54 | 55.39 |
BRC Group Holdings Inc is a diversified holding company offering a platform of businesses, including financial services (with complementary banking and wealth management businesses), telecom, retail, and investments in equity, debt, and venture capital. It serves retail, corporate, capital providers, and individual customers across different business lines. The Group reports its activities in seven reportable business segments: Capital Markets, Wealth Management, Lingo, magicJack, Marconi Wireless, UOL, and Consumer Products. Maximum revenue is generated from the Consumer Products segment, which offers mobile computing accessories and home furnishing products. Geographically, the Group derives its revenue from North America.
Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.